Trials / Completed
CompletedNCT00437463
Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor
Treatment of Early Immunoglobulin A Nephropathy by ACE Inhibitor - a Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of the ACE inhibitor ramipril in the treatment of early IgA nephropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ramipril | 2.5mg and increase to 5mg if patient do not develop symptomatic hypotension |
Timeline
- Start date
- 2004-07-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2007-02-21
- Last updated
- 2010-11-18
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT00437463. Inclusion in this directory is not an endorsement.